Geron's cancer screening patent rejected as non-patentable under Indian law
A cancer screening patent from US-based biotechnology company Geron Corp. was rejected as non-patentable by the Delhi High Court in a ruling that emphasized India’s strict patent law and dismissed the relevance...To view the full article, register now.
Already a subscriber? Click here to view full article